Wolverine Asset Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-23,343
Closed -$173K – 1815
2026
Q1
$173K Buy
+23,343
New +$246K ﹤0.01% 1106
2025
Q1
– Sell
-1,133
Closed -$18.7K – 1701
2024
Q4
$18.7K Buy
+1,133
New +$17.6K ﹤0.01% 1302
2022
Q2
– Sell
-142,763
Closed -$1.73M – 2416
2022
Q1
$1.73M Buy
+142,763
New +$3M 0.02% 554

Other funds holding NEO

Wolverine Asset Management's NEO Position: Q2 2026 in Review

Wolverine Asset Management sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 23,343 shares — an estimated $173K sold.

Wolverine Asset Management first reported a position in NEO in Q1 2022 and held it in 3 quarters. The position peaked at $1.73M in Q1 2022. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Wolverine Asset Management reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
  • Wolverine Asset Management sold 23,343 NeoGenomics shares in Q2 2026, an estimated $173K.
  • Wolverine Asset Management first reported a position in NeoGenomics in Q1 2022 and held it in 3 quarters.
  • Wolverine Asset Management's NeoGenomics position peaked at $1.73M in Q1 2022.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.